Impact of Coronavirus Disease–era Clinical Trial Reform on Cancer Trial Access in Rural/Underserved Regions of the Mid-West

Summary: The COVID-19 pandemic has brought significant changes to the environment in which cancer clinical trials are conducted, leading to adaptations by sponsors, cancer centers, and community oncology practices. These changes, including the use of telemedicine and remote informed consent procedures, are seen as long-term implementations to ensure the continuation of clinical investigations while improving access for underserved communities.